Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone

被引:3
|
作者
Varone, Francesco [1 ]
Mastrobattista, Annelisa [1 ]
Franchi, Paola [2 ]
Viglietta, Luca [1 ]
Poletti, Venerino [3 ,4 ]
Tomassetti, Sara [3 ]
Dubini, Alessandra [5 ]
Tagliaboschi, Linda [1 ]
Calandriello, Lucio [2 ]
Farchione, Alessandra [2 ]
Larici, Anna Rita [2 ]
机构
[1] Catholic Univ, A Gemelli Hosp, Cardiothorac Dept, Pulmonol Unit, Rome, Italy
[2] Catholic Univ, A Gemelli Hosp, Inst Radiol, Dept Bioimaging & Radiol Sci, Rome, Italy
[3] GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy
[4] Aarhus Univ Hosp, Dept Resp Dis & Allergol, Aarhus, Denmark
[5] GB Morgagni L Pierantoni Hosp, Pathol Unit, Forli, Italy
关键词
idiopathic pulmonary fibrosis; high-resolution computed tomography; honeycombing; multidisciplinary team; pirfenidone; DIAGNOSIS;
D O I
10.1111/crj.12515
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia associated with the histologic and/or radiologic pattern of usual interstitial pneumonia (UIP). Nowadays, the high-resolution computed tomography pattern of definite UIP is enough to define a diagnosis of UIP without histological proof. This is pivotal especially in elderly patients with comorbidities. Early recognition of IPF is relevant for its prognostic implication. Some pharmacological strategies have been proposing novel molecules that tend to slow lung function decline, even though without healing fibrosis. We report a case of ex-heavy smoker male with IPF showing clinical and radiological improvement after 11 months of treatment with Pirfenidone. The definite diagnosis was challenging and it was reached by a multidisciplinary approach.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [31] Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature
    Imakura, Akeshi
    Toyoda, Yuko
    Sato, Seidai
    Koyama, Kazuya
    Nishimura, Haruka
    Kagawa, Kozo
    Takahashi, Naoki
    Naito, Nobuhito
    Murakami, Kojin
    Kawano, Hiroshi
    Azuma, Masahiko
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    JOURNAL OF MEDICAL INVESTIGATION, 2020, 67 (3-4) : 358 - 361
  • [32] Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
    Takahashi, Mari
    Horio, Yukihiro
    Takihara, Takahisa
    Enokida, Keito
    Miyaoka, Masashi
    Hirabayashi, Kenichi
    Ohshinden, Kana
    Hattori, Shigeaki
    Takahashi, Fuminari
    Takahashi, Genki
    Tanaka, Jun
    Takiguchi, Hiroto
    Niimi, Kyoko
    Ito, Yoko
    Hayama, Naoki
    Oguma, Tsuyoshi
    Asano, Koichiro
    INTERNAL MEDICINE, 2021, 60 (04) : 617 - 621
  • [33] Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis
    Derlin, Thorsten
    Jaeger, Benedikt
    Jonigk, Danny
    Apel, Rosa M.
    Freise, Julia
    Shin, Hoen-Oh
    Weiberg, Desiree
    Warnecke, Gregor
    Ross, Tobias L.
    Wester, Hans-Jurgen
    Seeliger, Benjamin
    Welte, Tobias
    Bengel, Frank M.
    Prasse, Antje
    CHEST, 2021, 159 (03) : 1094 - 1106
  • [34] Relationship of flow-volume curve pattern on pulmonary function test with clinical and radiological features in idiopathic pulmonary fibrosis
    Nakagawa, Hiroaki
    Otoshi, Ryota
    Isomoto, Kohsuke
    Katano, Takuma
    Baba, Tomohisa
    Komatsu, Shigeru
    Hagiwara, Eri
    Nakano, Yasutaka
    Kuwahira, Ichiro
    Ogura, Takashi
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [35] Pirfenidone: an orphan drug for treating idiopathic pulmonary fibrosis
    Miura, Yukiko
    Azuma, Arata
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 587 - 597
  • [36] Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis
    Yoon, Hee-Young
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATION, 2019, 97 (03) : 242 - 251
  • [37] Pirfenidone: A Review of Its Use in Idiopathic Pulmonary Fibrosis
    Esther S. Kim
    Gillian M. Keating
    Drugs, 2015, 75 : 219 - 230
  • [38] Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series
    Ravaglia, Claudia
    Gurioli, Carlo
    Romagnoli, Micaela
    Casoni, GianLuca
    Tomassetti, Sara
    Gurioli, Christian
    Poletti, Venerino
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [39] Pirfenidone: A guide to its use in idiopathic pulmonary fibrosis
    Gillian M. Keating
    Katherine A. Lyseng-Williamson
    Natalie J. Carter
    Drugs & Therapy Perspectives, 2012, 28 (7) : 10 - 13
  • [40] Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis
    Trawinska, Maria A.
    Rupesinghe, Ruwani D.
    Hart, Simon P.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 563 - 574